BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tourki B, Black LM, Kain V, Halade GV. Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure. Biomed Pharmacother 2021;139:111574. [PMID: 33862495 DOI: 10.1016/j.biopha.2021.111574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei Z, Xie Y, Wei M, Zhao H, Ren K, Feng Q, Xu Y. New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1020918] [Reference Citation Analysis]
2 Yasin M, Shahid W, Ashraf M, Saleem M, Muzaffar S, Aziz-Ur-Rehman, Ejaz SA, Mahmood HMK, Bhattarai K, Riaz N. Targeting new N-furfurylated 4-chlorophenyl-1,2,4-triazolepropionamide hybrids as potential 15-lipoxygenase inhibitors supported with in vitro and in silico studies. J Biomol Struct Dyn 2022;:1-17. [PMID: 35699270 DOI: 10.1080/07391102.2022.2080765] [Reference Citation Analysis]
3 Kain V, Mat Y, Halade GV. Interaction of aging with lipoxygenase deficiency initiates hypersplenism, cardiac dysfunction, and profound leukocyte directed non-resolving inflammation. Geroscience 2021. [PMID: 34932185 DOI: 10.1007/s11357-021-00496-x] [Reference Citation Analysis]
4 B Gowda S, Gowda D, Kain V, Chiba H, Hui SP, Chalfant CE, Parcha V, Arora P, Halade GV. Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts. Am J Physiol Heart Circ Physiol 2021;321:H599-611. [PMID: 34415189 DOI: 10.1152/ajpheart.00314.2021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]